CEA Carcinoembryonic Antigen Test – Comprehensive Cancer Monitoring
Understanding the CEA Carcinoembryonic Antigen Test
The CEA Carcinoembryonic Antigen Test represents a cornerstone in modern cancer diagnostics and monitoring. This sophisticated blood test measures the levels of carcinoembryonic antigen, a glycoprotein that plays a crucial role in cancer detection and management. Originally discovered in 1965, CEA testing has evolved into an essential tool for oncologists and gastroenterologists worldwide, providing valuable insights into cancer progression, treatment effectiveness, and potential recurrence.
What Does the CEA Test Measure?
The CEA Carcinoembryonic Antigen Test specifically detects and quantifies the presence of carcinoembryonic antigen in your bloodstream. This protein is normally produced during fetal development but should be present in very low levels or absent in healthy adults. Elevated CEA levels can indicate:
- Colorectal cancer development and progression
- Other gastrointestinal cancers including stomach and pancreatic cancer
- Lung cancer and breast cancer presence
- Inflammatory bowel diseases and certain benign conditions
Who Should Consider CEA Testing?
This test is particularly important for several patient groups who may benefit from regular monitoring:
Individuals with Cancer History
Patients with a history of colorectal cancer, lung cancer, breast cancer, or other CEA-producing malignancies should undergo regular CEA testing to monitor for potential recurrence. The test serves as an early warning system, often detecting recurrence before symptoms appear or imaging changes become evident.
Patients Undergoing Cancer Treatment
For individuals currently receiving cancer therapy, serial CEA measurements provide critical feedback about treatment effectiveness. Decreasing CEA levels typically indicate positive response to therapy, while rising levels may suggest the need for treatment adjustment.
High-Risk Screening Candidates
Individuals with strong family histories of cancer, genetic predispositions, or concerning symptoms such as unexplained weight loss, persistent abdominal pain, or changes in bowel habits may benefit from CEA screening as part of their comprehensive health assessment.
Clinical Benefits of CEA Testing
The CEA Carcinoembryonic Antigen Test offers multiple advantages in cancer care and prevention:
Early Detection Capabilities
While not typically used as a standalone screening test for the general population, CEA monitoring in high-risk individuals can detect cancer recurrence or progression at earlier, more treatable stages. This early detection significantly improves treatment outcomes and survival rates.
Treatment Monitoring Precision
By tracking CEA levels throughout cancer therapy, healthcare providers can objectively assess treatment response. This quantitative approach helps optimize treatment plans and make timely adjustments when necessary.
Prognostic Value
Baseline CEA levels and their rate of change provide valuable prognostic information, helping physicians predict disease course and tailor follow-up strategies to individual patient needs.
Understanding Your Test Results
Interpreting CEA test results requires professional medical expertise, but understanding the general principles can help patients participate more actively in their care:
Normal Range Interpretation
Normal CEA levels typically fall below 3-5 ng/mL in non-smokers and slightly higher in smokers. However, reference ranges may vary between laboratories, so always consult with your healthcare provider for specific interpretation.
Elevated Levels Context
Mild to moderate CEA elevations can occur in various benign conditions including liver disease, inflammatory bowel disease, pancreatitis, and smoking. Significant elevations, particularly rising trends over time, are more concerning for malignancy.
Trend Analysis Importance
Single CEA measurements are less informative than serial measurements showing trends. Consistent increases over time typically warrant further investigation, while decreasing levels generally indicate positive treatment response.
Test Details and Pricing
| Test Parameter | Details |
|---|---|
| Test Name | CEA Carcinoembryonic Antigen Test |
| Discount Price | $20 USD |
| Regular Price | $22 USD |
| Turnaround Time | Daily |
| Sample Type | 2 mL (1 mL min.) serum from 1 SST |
| Shipping Requirements | Refrigerated or frozen |
| Testing Method | Chemiluminescent Microparticle Immunoassay |
Nationwide Accessibility
General Genetics Corporation maintains comprehensive testing facilities across the United States, ensuring convenient access to CEA testing in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified laboratories guarantees consistent, high-quality results regardless of your location.
Take Control of Your Health Today
Don’t wait to take proactive steps in your cancer monitoring and prevention journey. The CEA Carcinoembryonic Antigen Test provides valuable insights that can significantly impact your health outcomes. With our affordable pricing at just $20 and daily turnaround, there’s no reason to delay this important health assessment.
Ready to schedule your CEA test? Contact our dedicated healthcare team today at +1(267) 388-9828 or visit your nearest General Genetics Corporation facility. Our experienced staff will guide you through the simple testing process and ensure you receive comprehensive support throughout your healthcare journey.
Early detection and regular monitoring can make all the difference in cancer management. Trust General Genetics Corporation for accurate, reliable CEA testing you can count on.